Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection

NCT01975675 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic HCV Infection

Interventions

DRUG: LDV/SOF
DRUG: RBV

Sponsor

Gilead Sciences